Don't they need shareholders' approval before they can sell the company to a third party? If so, I am saying no to a cheap take over!
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025